Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company developing cell and gene therapies for life-threatening diseases. Its FDA-approved product ZEVASKYN treats wounds in patients with recessive dystrophic epidermolysis bullosa (RDEB).
Description via Wikipedia
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.